Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Michael Hill's publication output changed over time?
ScholarIQpublication output · 1996–2022
Output declined50% over the shown period — from 2 works in 1996 to 1 in 2022.
2
1
1
1
1
1
1
1
1
1
1996200220032008201120132016201820192022
What are the most-cited papers on Michael Hill?
ScholarIQmost cited works
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent, Martin Landray, Christina Reith, Jonathan Emberson, David C. Wheeler, Charles Tomson, Christoph Wanner, Vera Krane, Alan Cass, Jonathan C. Craig, Bruce Neal, Lixin Jiang, Lai Seong Hooi, Adeera Levin, Lawrence Y. Agodoa, Mike Gaziano, Bertram L. Kasiske, Robert Walker, Ziad A. Massy, Bo Feldt‐Rasmussen, Udom Krairittichai, Vuddidhej Ophascharoensuk, Bengt Fellström, Hallvard Holdaas, Vladimı́r Tesař, Andrzej Więcek, Diederick E. Grobbee, Dick de Zeeuw, Carola Grönhagen‐Riska, Tanaji Dasgupta, David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins
The Lancet. 20112,477 Citations
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure
Martin G. St. John Sutton, Ted Plappert, William T. Abraham, Andrew L. Smith, David B. DeLurgio, Angel R. León, Evan Loh, Dusan Z. Kocovic, Westby G. Fisher, Myrvin Ellestad, John C. Messenger, Kristin M. Kruger, Kathryn Hilpisch, Michael Hill
Circulation. 20031,128 CitationsOPEN ACCESS
Tissue Doppler Echocardiographic Evidence of Reverse Remodeling and Improved Synchronicity by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure
Cheuk‐Man Yu, Elaine Chau, John E. Sanderson, Katherine Fan, MAN‐OI TANG, Wing-Hong Fung, Hong Lin, Shun‐Ling Kong, Yui‐Ming Lam, Michael Hill, Chu‐Pak Lau
Circulation. 20021,111 CitationsOPEN ACCESS
A genome-wide search for quantitative trait loci underlying asthma
Susan E. Daniels, S.S. Bhattacharrya, Alan James, N. I. Leaves, A. P. Young, Michael Hill, J A Faux, Gerrard F. Ryan, Peter N. Le Souëf, G.M. Lathrop, Arthur W. Musk, W. O. C. M. Cookson
Nature. 1996788 Citations
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
HPS2-THRIVE Collaborative Group, R. Haynes, Lixin Jiang, Jemma C. Hopewell, Jing Li, F Chen, S. Parish, Martin Landray, R. Collins, J. Armitage, R. Collins, J. Armitage, C. Baigent, Z. Chen, Martin Landray, Yang Chen, Lixin Jiang, Terje Pedersen, Martin Landray, Louise Bowman, F Chen, Michael Hill, R. Haynes, Carol Knott, Kazem Rahimi, Jonathan A. Tobert, Peter Sleight, David Simpson, S. Parish, Alex Baxter, M. Lay, Christopher Bray, E. Wincott, G. van Leijenhorst, A. Skattebøl, Gro Kvelprud Moen, Yale Mitchel, O. Kuznetsova, Stephen MacMahon, John Kjekshus, Catherine J. Hill, TH Lam, Peter Sandercock, Richard Peto, Jemma C. Hopewell
European Heart Journal. 2013674 CitationsOPEN ACCESS
Related on ScholarIQ
University of Oxford
Institution
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Paper
Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure
Paper
Tissue Doppler Echocardiographic Evidence of Reverse Remodeling and Improved Synchronicity by Simultaneously Delaying Regional Contraction After Biventricular Pacing Therapy in Heart Failure
Paper
A genome-wide search for quantitative trait loci underlying asthma
Paper
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
Paper